Nasal and temporal hemifield (14×24°) pattern electroretinograms (PERGs) were recorded in eight patients (age range: 21–72 years) suffering from different post-geniculate lesions (documented by CT scan and/or MRI of the brain) and homonymous hemianopia at visual field testing. In total eight age-matched normal subjects served as controls. PERGs were elicited by alternating, sinusoidal gratings (90% contrast), whose spatial and temporal characteristics, 6 Hz–5 c deg −1 and 15 Hz–0.58 c deg −1, were chosen to enhance the relative contributions of parvo- (P) and magno- (M) retinal ganglion cell (GC) subsystems, respectively. Amplitudes and phases of the Fourier analyzed PERG 2nd harmonics were measured. In normal subjects, PERG amplitudes to 15 Hz–0.58 c deg −1, but not those of the 6 Hz–5 c deg −1 stimuli were on average larger ( P<0.05) in nasal than in temporal hemiretinae. In hemianopic patients, PERG amplitudes of 6 Hz–5 c deg −1 stimuli were on average reduced ( P<0.05) in the hemiretinae corresponding to blind hemifields, in comparison to those in the hemiretinae corresponding to functional hemifields. No differences between hemiretinae were observed for responses of the 15 Hz–0.58 c deg −1 stimuli. In both normal subjects and patients, average PERG phases did not differ between hemiretinae, while changing significantly ( P<0.01) across stimulus conditions. The PERG naso-temporal asymmetries observed in normal subjects are consistent with the reported asymmetries in GC density observed histologically (Curcio & Allen. (1990). Journal of Comparative Neurology, 300, 5–25). The results in patients indicate that the PERGs to specific spatio–temporal stimuli (i.e. of relatively low-temporal and high-spatial frequency), presented in the hemianopic field, are reduced in amplitude. This suggests, in agreement with the experimental findings in monkeys (Cowey & Stoerig. (1991). Trends in Neuroscience, 14, 140–145), that retrograde trans-synaptic dysfunction of P-GCs, with relative sparing of the M-subsystem, may occur in humans following lesions of post-geniculate pathways.